Prudential Financial Inc Fulcrum Therapeutics, Inc. Transaction History
Prudential Financial Inc
- $70.8 Billion
- Q4 2024
A detailed history of Prudential Financial Inc transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 22,675 shares of FULC stock, worth $71,426. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,675
Previous 22,675
-0.0%
Holding current value
$71,426
Previous $80,000
32.5%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding FULC
# of Institutions
130Shares Held
51.6MCall Options Held
1.04MPut Options Held
32.6K-
Ra Capital Management, L.P. Boston, MA10.2MShares$32.2 Million0.78% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$16.5 Million4.03% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$15.1 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.78MShares$15.1 Million1.13% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.34MShares$10.5 Million0.65% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $164M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...